AIM ImmunoTech (AIM) Asset Utilization Ratio (2011 - 2026)
AIM ImmunoTech's (AIM) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, down 33.43% YoY from 0.02 in Q1 2025, and down 16.16% on a QoQ basis from 0.02 in Q4 2025.
AIM ImmunoTech (AIM) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 15 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 33.43% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 33.43% YoY) and the FY2025 annual result came in at 0.01, up 0.68% from the prior year.
- Asset Utilization Ratio declined to 0.01 in Q1 2026, from 0.02 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q2 2025 to a low of 0.0 in Q1 2022.
- A 5-year average of 0.01 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 171.12% — and 2026, when it slumped 33.43%.
- Tracing AIM's Asset Utilization Ratio over 5 years: stood at 0.0 in 2022, then surged by 165.02% to 0.01 in 2023, then jumped by 79.12% to 0.02 in 2024, then gained by 1.9% to 0.02 in 2025, then slipped by 16.16% to 0.01 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 0.13 |
| 10 | AIM ImmunoTech | 4.48 Mn | -5.48 Mn | 21,000.00 | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |